Showing 741-750 of 5846 results for "".
AK Therapy: Real-life Approaches to Combinations on Scientifically Speaking
https://practicaldermatology.com/topics/skin-cancer-photoprotection/ak-therapy-real-life-approaches-to-combinations-on-scientifically-speaking/19913/From serial PDT to novel combinations, specialists describe how they treat AKs in real-world settings. Scientifically Speaking host Joel L. Cohen, MD reviews cases from Neal Bhatia, MD, Michael H. Gold, MD, and George Martin, MD.Scientifically Speaking: Optimized Approaches to AK Management
https://practicaldermatology.com/topics/skin-cancer-photoprotection/scientifically-speaking-optimized-approaches-to-ak-management/19912/What's new in AK therapy? From a new, first-in-class molecule to updated approaches with long-standing treatments, the management of actinic keratosis continues to evolve. Scientifically Speaking host Joel L. Cohen, MD speaks with Neal Bhatia, MD, Michael H. Gold, MD, and George Martin, MD about theDermWireTV: Pulse's CellFX, Soliton's RAP Technology, Belotero Balance (+), Restylane Defyne, Eczema Costs
https://practicaldermatology.com/series/dermwire-tv/dermwiretv-pulses-cellfx-solitons-rap-technology-belotero-balance-restylane-defyne-eczema-costs/19899/The FDA has cleared Pulse Biosciences’ CellFX system, and a commercial rollout will begin soon. There’s another new option for treatment for legs with FDA clearance of Soliton’s Rapid Acoustic Pulse technology for cellulite. For eight percent of Americans with atopic dermatitis, annual out of pocketScientifically Speaking: Applying Energy-Based Devices Across Skin Tones
https://practicaldermatology.com/series/scientifically-speaking/scientifically-speaking-applying-energy-based-devices-across-skin-tones/19895/With advancements in technology and a patient-focused approach to treatment, it's possible to safely and effectively apply energy-based devices to a range of skin concerns in patients with darker skin. Host Joel L. Cohen, MD discusses treatment strategies for melasma, acne, PFB, scarring and more wiDermWireTV: Cassiopeia Winlevi; Psoriasis Guidelines; Cyndi Lauper's PsO in the Know; Sarah Michelle Gellar's CoolSculpting
https://practicaldermatology.com/topics/psoriasis/dermwiretv-cassiopeia-winlevi-psoriasis-guidelines-cyndi-laupers-pso-in-the-know-sarah-michelle-gellars-coolsculpting/19852/The FDA has approved Winlevi (Clascoterone cream 1%) from Cassiopea for the treatment of acne in patients 12 years and older.New Guidelines of care for the Management of Psoriasis with Systemic Nonbiologic Therapies, jointly issued by the American Academy of Dermatology and the National Psoriasis FoDERM2020 Content Recap: Kara Gooding, PA-C
https://practicaldermatology.com/conferences/dermatology-education-foundation-derm-2020/derm2020-content-recap-kara-gooding-pa-c/19841/DERM2020 Faculty Kara Gooding, PA-C talks a bit about the case she presented at DERM2020.How Does Consideration of the Microbiome Affect Topical Product Selection
https://practicaldermatology.com/topics/atopic-dermatitis/how-does-consideration-of-the-microbiome-affect-topical-product-selection/19827/A healthy microbiome is a hallmark of healthy skin, while dysbiosis is implicated in various dermatologic diseases. Dr. Friedman explains how this knowledge should influence topical skin care.How Do You Treat Alopecia Areata of the Eyebrows?
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/how-do-you-treat-alopecia-areata-of-the-eyebrows/19822/Intralesional corticosteroids are a key part of treatment. Dr. Friedman discusses safe use, as well as additional treatment strategies.Continuity of Psoriasis Care in the Era of COVID-19
https://practicaldermatology.com/columns/clinical-focus-1/continuity-of-psoriasis-care-in-the-era-of-covid-19/23285/While there’s no data about susceptibility to COVID-19 in psoriasis, there is relevant information on infectious complications from biologics.COVID-19 Impact: Navigating Clinical Research
https://practicaldermatology.com/series/dermatology-dispatches/covid-19-impact-navigating-clinical-research/19771/Conducting clinical research studies is challenging as the majority of Americans are under stay-at-home orders for the forseeable future due to the COVID-19 pandemic, says Todd E. Schlesinger, MD. He suggests trialists do their best to say in contact with clinical research organizations, sponsors, a